The Commercial Trajectory of NGS-Based vs. Flow Cytometry Testing: Analyzing 2026 Shifts in Molecular Sensitivity (2026–2033)
Minimal Residual Disease Market Summary: According to the latest report published by Data Bridge Market Research, the Minimal Residual Disease Market  The minimal residual disease market size was valued at USD 2.13 billion in 2024 and is projected to reach USD 3.92 billion by 2032, with a CAGR of 7.90% during the forecast period of 2025 to 2032. The winning Minimal Residual...
0 Commentaires 0 Parts 410 Vue